{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:22:42Z","timestamp":1795173762482,"version":"4.10.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the CAMS Innovation Fund for Medical Sciences","award":["2022-I2M-C&T-A-010"],"award-info":[{"award-number":["2022-I2M-C&T-A-010"]}]},{"name":"the National Key Research and Development Program of China","award":["2016YFC1300100"],"award-info":[{"award-number":["2016YFC1300100"]}]},{"name":"the Suzhou Industrial Park Xinxin Cardiovascular Health Foundation \"Progress \u00b7 Progress Fund 2020\" funded project","award":["2020-CCA-ACCESS-120"],"award-info":[{"award-number":["2020-CCA-ACCESS-120"]}]},{"name":"the Drug Research Fund for Cardiac Rehabilitation and Metabolic Therapy","award":["T2016-ZX027"],"award-info":[{"award-number":["T2016-ZX027"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82192902"],"award-info":[{"award-number":["82192902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is an increased risk of diabetes and cardiovascular disease among patients with psoriasis. However, whether diabetes affects the cardiovascular adverse events in patients with psoriasis who have suffered from coronary artery disease remains unclear. This study aimed to explore the prognostic role of diabetes in this particular population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, retrospective cohort study included all consecutive adult patients with psoriasis and coronary artery disease admitted at our hospital between January 2017 and May 2022. Clinical records were collected and compared between patients with and without diabetes. Survival curves were derived using Kaplan\u2013Meier methods. Multivariable Cox regression was used to control potential confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study included 305 participants, including 147 patients (48.2%) with diabetes. Patients with diabetes were more likely to have hypertension (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045), peripheral vascular disease (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043) and the history of stroke (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.041). Patients with diabetes also had higher levels of low-density lipoprotein cholesterol (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039) and homocysteine (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006). After a median follow-up of 36 months, patients with diabetes had a higher incidence of major adverse cardiovascular events (MACE) than patients without diabetes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.032). According to the results of the Cox regression analysis, only diabetes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039) was associated with MACE. The subgroup analysis showed that diabetes was associated with MACE, especially in male patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) and those without chronic kidney disease (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with psoriasis and coronary artery disease, diabetes is independently linked with MACE. These findings will help the risk assessment for patients with psoriasis and coronary artery disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-025-01996-z","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:18:50Z","timestamp":1752466730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetes is associated with a poor prognosis in patients with psoriasis and coronary artery disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Lin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KunQi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZengLei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZuoZhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XianLiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiXian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"5","key":"1996_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496\u2013509.","journal-title":"N Engl J Med"},{"key":"1996_CR2","doi-asserted-by":"publisher","first-page":"743180","DOI":"10.3389\/fmed.2021.743180","volume":"8","author":"G Damiani","year":"2021","unstructured":"Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, Guo C, Dellavalle R, Grada A, Wong P, et al. The global, regional, and National burden of psoriasis: results and insights from the global burden of disease 2019 study. Front Med. 2021;8:743180.","journal-title":"Front Med"},{"key":"1996_CR3","doi-asserted-by":"crossref","unstructured":"Liu S, Yan Z, Liu Q. The Burden of Psoriasis in China and Global Level from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019. Biomed Res Int 2022, 2022:3461765.","DOI":"10.1155\/2022\/3461765"},{"key":"1996_CR4","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"key":"1996_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fphar.2020.00117","volume":"11","author":"P Gisondi","year":"2020","unstructured":"Gisondi P, Bellinato F, Girolomoni G, Albanesi C. Pathogenesis of chronic plaque psoriasis and its intersection with Cardio-Metabolic comorbidities. Front Pharmacol. 2020;11:117.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1996_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1996_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","volume":"149","author":"AW Armstrong","year":"2013","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatology. 2013;149(1):84\u201391.","journal-title":"JAMA Dermatology"},{"issue":"2","key":"1996_CR8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.dsx.2019.01.009","volume":"13","author":"M Mamizadeh","year":"2019","unstructured":"Mamizadeh M, Tardeh Z, Azami M. The association between psoriasis and diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Syndr. 2019;13(2):1405\u201312.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"1996_CR9","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","volume":"69","author":"IM Miller","year":"2013","unstructured":"Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol. 2013;69(6):1014\u201324.","journal-title":"J Am Acad Dermatol"},{"key":"1996_CR10","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.2147\/DMSO.S273147","volume":"13","author":"R Abramczyk","year":"2020","unstructured":"Abramczyk R, Queller JN, Rachfal AW, Schwartz SS. Diabetes and psoriasis: different sides of the same Prism. Diabetes Metab Syndr Obes. 2020;13:3571\u20137.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"1996_CR11","doi-asserted-by":"publisher","first-page":"19683","DOI":"10.1038\/s41598-024-70707-w","volume":"14","author":"P Cui","year":"2024","unstructured":"Cui P, Li D, Shi L, Yan H, Li T, Liu C, Wang W, Zheng H, Ding N, Li X, et al. Cardiovascular comorbidities among patients with psoriasis: a National register-based study in China. Sci Rep. 2024;14(1):19683.","journal-title":"Sci Rep"},{"issue":"1","key":"1996_CR12","doi-asserted-by":"publisher","first-page":"e13550","DOI":"10.1111\/srt.13550","volume":"30","author":"J Pan","year":"2024","unstructured":"Pan J, Chang X, Wang L, Miao G, Jin Q, Guo N, Zhang J, Lv Y, Wang L. Use of biologics in patients with psoriasis - A retrospective analysis based on real-world data. Skin Res Technol. 2024;30(1):e13550.","journal-title":"Skin Res Technol"},{"issue":"7","key":"1996_CR13","first-page":"718","volume":"21","author":"KS Kommoss","year":"2023","unstructured":"Kommoss KS, Enk A, Heikenw\u00e4lder M, Waisman A, Karbach S, Wild J. Cardiovascular comorbidity in psoriasis - psoriatic inflammation is more than just skin deep. J Der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatology: JDDG. 2023;21(7):718\u201325.","journal-title":"J Der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatology: JDDG"},{"issue":"5","key":"1996_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/dmrr.2827","volume":"32","author":"J Weng","year":"2016","unstructured":"Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D, Zhu D, Chen L, Chen L, Guo L, et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016;32(5):442\u201358.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1996_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","volume":"81","author":"A Elenkova","year":"2020","unstructured":"Elenkova A, Matrozova J, Vasilev V, Robeva R, Zacharieva S. Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study. Ann Endocrinol (Paris). 2020;81(1):3\u201310.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"1996_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 international society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"17","key":"1996_CR17","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344\u201351.","journal-title":"Circulation"},{"issue":"9","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"12","key":"1996_CR19","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.amjcard.2018.04.058","volume":"122","author":"N Xu","year":"2018","unstructured":"Xu N, Tang XF, Yao Y, Zhao XY, Chen J, Gao Z, Qiao SB, Yang YJ, Gao RL, Xu B, et al. Association of plasma Lipoprotein(a) with Long-Term adverse events in patients with chronic kidney disease who underwent percutaneous coronary intervention. Am J Cardiol. 2018;122(12):2043\u20138.","journal-title":"Am J Cardiol"},{"issue":"14","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735\u201341.","journal-title":"JAMA"},{"issue":"8","key":"1996_CR21","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","volume":"31","author":"NN Mehta","year":"2010","unstructured":"Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J. 2010;31(8):1000\u20136.","journal-title":"Eur Heart J"},{"issue":"1","key":"1996_CR22","doi-asserted-by":"publisher","first-page":"11548","DOI":"10.1038\/s41598-022-15436-8","volume":"12","author":"OC Kwon","year":"2022","unstructured":"Kwon OC, Han K, Chun J, Kim R, Hong SW, Kim JH, Youn YH, Park H, Park MC. Effects of immune-mediated inflammatory diseases on cardiovascular diseases in patients with type 2 diabetes: a nationwide population-based study. Sci Rep. 2022;12(1):11548.","journal-title":"Sci Rep"},{"key":"1996_CR23","doi-asserted-by":"crossref","unstructured":"Piaserico S, Orlando G, Messina F. Psoriasis and cardiometabolic diseases: shared genetic and molecular pathways. Int J Mol Sci 2022, 23(16).","DOI":"10.3390\/ijms23169063"},{"issue":"11","key":"1996_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/exd.13393","volume":"26","author":"H Wang","year":"2017","unstructured":"Wang H, Wang Z, Rani PL, Fu X, Yu W, Bao F, Yu G, Li J, Li L, Sun L, et al. Identification of PTPN22, ST6GAL1 and JAZF1 as psoriasis risk genes demonstrates shared pathogenesis between psoriasis and diabetes. Exp Dermatol. 2017;26(11):1112\u20137.","journal-title":"Exp Dermatol"},{"issue":"2","key":"1996_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/jmg.2007.053595","volume":"45","author":"N Wolf","year":"2008","unstructured":"Wolf N, Quaranta M, Prescott NJ, Allen M, Smith R, Burden AD, Worthington J, Griffiths CE, Mathew CG, Barker JN, et al. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet. 2008;45(2):114\u20136.","journal-title":"J Med Genet"},{"key":"1996_CR26","doi-asserted-by":"publisher","first-page":"605691","DOI":"10.3389\/fmed.2021.605691","volume":"8","author":"V Brazzelli","year":"2021","unstructured":"Brazzelli V, Maffioli P, Bolcato V, Ciolfi C, D\u2019Angelo A, Tinelli C, Derosa G. Psoriasis and diabetes, a dangerous association: evaluation of insulin resistance, lipid abnormalities, and cardiovascular risk biomarkers. Front Med. 2021;8:605691.","journal-title":"Front Med"},{"key":"1996_CR27","doi-asserted-by":"publisher","first-page":"890195","DOI":"10.3389\/fmed.2022.890195","volume":"9","author":"S Ramos","year":"2022","unstructured":"Ramos S, Daya S, Crowther NJ, Pillay L, Tikly M, Goolam Mahyoodeen N. Prevalence and predictors of abdominal aorta calcification in patients with Psoriasis-A case control study. Front Med. 2022;9:890195.","journal-title":"Front Med"},{"issue":"7","key":"1996_CR28","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/ATVBAHA.114.303268","volume":"34","author":"MH Criqui","year":"2014","unstructured":"Criqui MH, Denenberg JO, McClelland RL, Allison MA, Ix JH, Guerci A, Cohoon KP, Srikanthan P, Watson KE, Wong ND. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(7):1574\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"1996_CR29","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","volume":"103","author":"PW Wilson","year":"2001","unstructured":"Wilson PW, Kauppila LI, O\u2019Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 2001;103(11):1529\u201334.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"1996_CR30","first-page":"S144","volume":"45","author":"ADAPP Committee","year":"2022","unstructured":"Committee ADAPP. 10. Cardiovascular disease and risk management: standards of medical care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S144\u201374.","journal-title":"Diabetes Care"},{"key":"1996_CR31","doi-asserted-by":"crossref","unstructured":"Lu J, Chen K, Chen W, Liu C, Jiang X, Ma Z, Li D, Shen Y, Tian H. Association of Serum Homocysteine with Cardiovascular and All-Cause Mortality in Adults with Diabetes: A Prospective Cohort Study. Oxid Med Cell Longev 2022, 2022:2156483.","DOI":"10.1155\/2022\/2156483"},{"issue":"9","key":"1996_CR32","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1002\/fsn3.1818","volume":"8","author":"T Rehman","year":"2020","unstructured":"Rehman T, Shabbir MA, Inam-Ur-Raheem M, Manzoor MF, Ahmad N, Liu ZW, Ahmad MH, Siddeeg A, Abid M, Aadil RM. Cysteine and homocysteine as biomarker of various diseases. Food Sci Nutr. 2020;8(9):4696\u2013707.","journal-title":"Food Sci Nutr"},{"issue":"10","key":"1996_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1139\/cjpp-2018-0112","volume":"96","author":"D Djuric","year":"2018","unstructured":"Djuric D, Jakovljevic V, Zivkovic V, Srejovic I. Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems. Can J Physiol Pharmacol. 2018;96(10):991\u20131003.","journal-title":"Can J Physiol Pharmacol"},{"issue":"SupplSuppl","key":"1996_CR34","doi-asserted-by":"publisher","first-page":"S376","DOI":"10.1194\/jlr.R800087-JLR200","volume":"50","author":"D Steinberg","year":"2009","unstructured":"Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2009;50(SupplSuppl):S376\u2013381.","journal-title":"J Lipid Res"},{"key":"1996_CR35","doi-asserted-by":"crossref","unstructured":"Jung E, Kong SY, Ro YS, Ryu HH, Shin SD. Serum cholesterol levels and risk of cardiovascular death: A systematic review and a Dose-Response Meta-Analysis of prospective cohort studies. Int J Environ Res Public Health 2022, 19(14).","DOI":"10.3390\/ijerph19148272"},{"key":"1996_CR36","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.2147\/CCID.S393697","volume":"15","author":"Q Zheng","year":"2022","unstructured":"Zheng Q, Kuai L, Jiang W, Qiang Y, Wei L, Chen S, Li B, Wang R. Clinical feature, lifestyle behavior and Non-Communicable diseases comorbidities among psoriasis patients in shanghai: gender disparity analysis based on a Cross-Sectional study. Clin Cosmet Invest Dermatology. 2022;15:2751\u201362.","journal-title":"Clin Cosmet Invest Dermatology"},{"issue":"7","key":"1996_CR37","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","volume":"50","author":"P Ungprasert","year":"2018","unstructured":"Ungprasert P, Raksasuk S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(7):1277\u201383.","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"1996_CR38","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s13555-023-00986-0","volume":"13","author":"A Buja","year":"2023","unstructured":"Buja A, Miatton A, Cozzolino C, Brazzale AR, Lo Bue R, Mercuri SR, Proft FN, Kridin K, Cohen AD, Damiani G. The prevalent comorbidome at the onset of psoriasis diagnosis. Dermatology Therapy. 2023;13(9):2093\u2013105.","journal-title":"Dermatology Therapy"},{"issue":"6","key":"1996_CR39","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s13555-023-00930-2","volume":"13","author":"G Damiani","year":"2023","unstructured":"Damiani G, Amerio P, Bardazzi F, Carrera CG, Conti A, Cusano F, Dapavo P, DeSimone C, El Hachem M, Fabbrocini G, et al. Real-World experience of methotrexate in the treatment of skin diseases: an Italian Delphi consensus. Dermatology Therapy. 2023;13(6):1219\u201341.","journal-title":"Dermatology Therapy"},{"issue":"10","key":"1996_CR40","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s13555-023-00987-z","volume":"13","author":"G Damiani","year":"2023","unstructured":"Damiani G, Pacifico A, Scoditti E, di Gregorio S, Del Fabbro M, Cozzolino C, Buja A, Mercuri SR, Bianchi VG, Grada A, et al. Circadian oscillations of minimal erythema dose (MED) are also influenced by diet in patients with psoriasis: A chronomedical study. Dermatology Therapy. 2023;13(10):2229\u201346.","journal-title":"Dermatology Therapy"},{"key":"1996_CR41","doi-asserted-by":"crossref","unstructured":"Pacifico A, Conic RRZ, Cristaudo A, Garbarino S, Ardig\u00f2 M, Morrone A, Iacovelli P, di Gregorio S, Pigatto PDM, Grada A et al. Diet-Related Phototoxic Reactions in Psoriatic Patients Undergoing Phototherapy: Results from a Multicenter Prospective Study. Nutrients 2021, 13(9).","DOI":"10.3390\/nu13092934"},{"issue":"2","key":"1996_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s13555-025-01338-w","volume":"15","author":"G Damiani","year":"2025","unstructured":"Damiani G, Pacifico A, Ricciardi S, Corazza V, Trigos D, Fiore M, Guarneri C. Management of systemic Anti-psoriatic drugs in psoriasis patients with concurrent paraplegia or tetraplegia: insights from a 6-Year multicenter, retrospective observational study. Dermatology Therapy. 2025;15(2):427\u201336.","journal-title":"Dermatology Therapy"},{"issue":"12","key":"1996_CR43","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1080\/14712598.2022.2093106","volume":"22","author":"E Trovato","year":"2022","unstructured":"Trovato E, Rubegni P, Prignano F. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome. Expert Opin Biol Ther. 2022;22(12):1443\u20138.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"1996_CR44","doi-asserted-by":"publisher","first-page":"2425029","DOI":"10.1080\/09546634.2024.2425029","volume":"35","author":"L Ibba","year":"2024","unstructured":"Ibba L, Di Giulio S, Gargiulo L, Facheris P, Perugini C, Costanzo A, Narcisi A, Valenti M. Long-term effectiveness and safety of Risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study. J Dermatolog Treat. 2024;35(1):2425029.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"1996_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/14712598.2024.2337242","volume":"24","author":"S Boskovic","year":"2024","unstructured":"Boskovic S, Borriello S, D\u2019Ascenzo F, Sciamarrelli N, Rosset F, Mastorino L, Paolo D, Bocchino PP, De Filippo O, Ribero S, et al. Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk. Expert Opin Biol Ther. 2024;24(4):217\u20139.","journal-title":"Expert Opin Biol Ther"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01996-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01996-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01996-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:01:06Z","timestamp":1757232066000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01996-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01996-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"3 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Fuwai Hospital (approval number: 2021\u2009\u2212\u20091544). All data was anonymized before analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"174"}}